A new JAMA study by GCDTR’s Roy W. Beck Jaeb Center for Health Research underscores a paradigm shift in diabetes care, especially for type 2 diabetes managed in primary care settings. Key takeaways: CGM offers real-time glucose data, potentially enhancing glycemic control beyond traditional HbA₁c and finger-stick metrics.
Primary care clinicians prescribing CGM may improve monitoring, treatment adjustment, and patient engagement in glucose self-management. Given the chronic and progressive nature of type 2 diabetes worldwide, especially in low-resource settings, integrating CGM into routine care could transform outcomes and empower patients.
